Jump to main content.


Pesticide Registration Improvement Extension Act (PRIA 3)
Fee Determination Decision Tree

Decision Tree Resources:

Below is the fee for your selected Fee Category for Fiscal Years 2014/2015

Action Code Description FY14/15
Fee
Decision Time
(months)
R315 New end-use non-food animal product with submission of two or more target animal safety studies; includes data and/or waivers of data for only: Product chemistry and/or Acute toxicity and/or Public health pest efficacy and/or Animal safety studies and/or Child resistant packaging (2) (3) $ 8,400 9

Do you plan to request either of the following types of waivers?


50% waiver You pay ---->>>>> $ 4,200  
75% waiver You pay ---->>>>> $ 2,100  

To pay the fee shown above, go to http://www.pay.gov and follow the instructions.

How to submit your application directly to EPA.


Action Code Interpretation

An application for registration of an end-use pesticide animal product that is not substantially similar or identical in its uses and formulation to a product currently registered. For example, spot-on and flea collars products are generally labeled animal specific, in that a product is labeled for dogs or cats, but not generally both, shampoos and sprays may be labeled for both species (dogs and cats). To fit this category all applications require the following:

  • A data matrix is required with the application.
  • Product chemistry data (Group A and B) and CSF. In some cases product chemistry data can be satisfied as outlined in Pesticide Registration Notice 98-1. If the source of the active ingredient in this application is not registered; the decision review time line will be the longest of the associated application (see timeline for - R333 or R334).
  • All of the inerts used in the product must be either approved or pending with the Agency for the applicable uses. In those cases where the product relies upon a pending inert clearance, the new companion animal studies must be conducted with the pending inert in the tested product in the same concentrations as is intended to be marketed and sold.
  • Acute toxicity, public health pest efficacy, child resistant packaging data, companion animal safety data and/or requirements must be addressed by using: 1) the cite-all method, or 2) selective data citation which includes submitting required data. A rationale for a waiver or bridging of these data falls within this category.
  • Appropriate companion animal safety studies based upon the specific label claims in the proposed label. For example, if the proposed end use product label claim is to use the product on 12 week old kittens weighing ≥3 lbs and on breeding cats, then two companion animal studies are required: the first using kittens ≥ 12 weeks of age and weighing at least 3 lbs. and a second study on pregnant and nursing adult cats. Each of these studies must demonstrate an adequate margin of safety.

An application proposed as a 100% re-packaged product does not fall within this category (see category R300). If an applicant owns the generic data and therefore does not qualify for the formulatorís exemption, the new product application belongs in this category. The application does not fall into this category if it contains a request to waive generic data or a request to review any generic data.

Applications for new end use products that are submitted using an unregistered source of an existing active ingredient will be recoded to either category R333 or R334. All active ingredients derived from a manufacturing source which does not hold an active EPA registration number are considered unregistered. Even if the Agency may have reviewed the product chemistry data previously for that unregistered source of the active ingredient for another end use product, the active ingredient is considered unregistered.

The Agency will provide the applicant with a pre-decisional determination 2 weeks prior to the PRIA decision review time due date which specifies any label changes that have to be made in order to grant the requested new end-use product registration. If the label issues cannot be resolved prior to the PRIA decision review time due date and if a PRIA due date time extension has not been agreed upon, then the Agency will issue to the applicant its regulatory decision with the specific label changes and supporting documentation on or just before the PRIA decision review time due date. At that time the applicant must either (a) agree to all of the label changes and submit a revised label that incorporates all of these label changes; or (b) does not agree with one or more of the label changes and request up to 30 days to reach agreement with the Agency and submit a revised label that incorporates all of the agreed upon label changes, which the Agency has 2 business days to review; or (c) withdraw the application without prejudice.


     Go to the start of the Decision Tree

Publications | Glossary | A-Z Index | Jobs


Local Navigation


Jump to main content.